The participation of interleukin-6 in the pathogenesis of Alzheimer's disease - PubMed (original) (raw)

Review

The participation of interleukin-6 in the pathogenesis of Alzheimer's disease

J Bauer et al. Res Immunol. 1992 Jul-Aug.

No abstract available

PubMed Disclaimer

Similar articles

• Microglia and immune activation in Alzheimer's disease.
  Gordon MN. Gordon MN. J Fla Med Assoc. 1993 Apr;80(4):267-70. J Fla Med Assoc. 1993. PMID: 7685046 Review.
• Cytokines and inflammatory proteins in Alzheimer's disease.
  Berkenbosch F, Biewenga J, Brouns M, Rozemuller JM, Strijbos P, van Dam AM. Berkenbosch F, et al. Res Immunol. 1992 Jul-Aug;143(6):657-63. doi: 10.1016/0923-2494(92)80052-m. Res Immunol. 1992. PMID: 1280851 Review. No abstract available.
• Alpha 2-macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells. Potential significance for the processing of Alzheimer beta-amyloid precursor protein.
  Ganter U, Strauss S, Jonas U, Weidemann A, Beyreuther K, Volk B, Berger M, Bauer J. Ganter U, et al. FEBS Lett. 1991 Apr 22;282(1):127-31. doi: 10.1016/0014-5793(91)80460-k. FEBS Lett. 1991. PMID: 1709116
• Study of interleukin-6 production in Alzheimer's disease.
  Cojocaru IM, Cojocaru M, Miu G, Sapira V. Cojocaru IM, et al. Rom J Intern Med. 2011;49(1):55-8. Rom J Intern Med. 2011. PMID: 22026253
• Proteases and Protease Inhibitors in Alzheimer's Disease Pathogenesis. Proceedings of a conference. Bethesda, Maryland, December 16-18, 1991.
  [No authors listed] [No authors listed] Ann N Y Acad Sci. 1992 Dec 31;674:1-259. Ann N Y Acad Sci. 1992. PMID: 1363188 No abstract available.

Cited by

• Effects of Supplementation with Folic Acid and Its Combinations with Other Nutrients on Cognitive Impairment and Alzheimer's Disease: A Narrative Review.
  Puga AM, Ruperto M, Samaniego-Vaesken ML, Montero-Bravo A, Partearroyo T, Varela-Moreiras G. Puga AM, et al. Nutrients. 2021 Aug 26;13(9):2966. doi: 10.3390/nu13092966. Nutrients. 2021. PMID: 34578844 Free PMC article. Review.
• Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI.
  Ma F, Wu T, Zhao J, Song A, Liu H, Xu W, Huang G. Ma F, et al. Sci Rep. 2016 Nov 23;6:37486. doi: 10.1038/srep37486. Sci Rep. 2016. PMID: 27876835 Free PMC article.
• Epistasis analysis links immune cascades and cerebral amyloidosis.
  Benedet AL, Labbe A, Lemay P, Zimmer ER, Pascoal TA, Leuzy A, Mathotaarachchi S, Mohades S, Shin M, Dionne-Laporte A, Beaudry T, Picard C, Gauthier S, Poirier J, Rouleau G, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative. Benedet AL, et al. J Neuroinflammation. 2015 Dec 1;12:227. doi: 10.1186/s12974-015-0436-z. J Neuroinflammation. 2015. PMID: 26626881 Free PMC article.
• Interleukin 6 and cognitive dysfunction.
  Trapero I, Cauli O. Trapero I, et al. Metab Brain Dis. 2014 Sep;29(3):593-608. doi: 10.1007/s11011-014-9551-2. Epub 2014 Apr 30. Metab Brain Dis. 2014. PMID: 24782046 Review.
• Sporadic Alzheimer disease fibroblasts display an oxidative stress phenotype.
  Ramamoorthy M, Sykora P, Scheibye-Knudsen M, Dunn C, Kasmer C, Zhang Y, Becker KG, Croteau DL, Bohr VA. Ramamoorthy M, et al. Free Radic Biol Med. 2012 Sep 15;53(6):1371-80. doi: 10.1016/j.freeradbiomed.2012.07.018. Epub 2012 Aug 3. Free Radic Biol Med. 2012. PMID: 22885031 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information